Dallas, Texas (PRWEB) August 21, 2014
One of the emerging trends that the Intranasal Drug Delivery market is likely to experience is an increasing adoption of non-invasive administration products. As non-invasive nasal drug delivery increases the compliance of the patient through their convenient application, they find more preference among end-users.
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.
According to the “Global Intranasal Drug Delivery Market 2014-2018” report, one of the major drivers in the market is the increasing aging population. With growing age, people are more susceptible to developing respiratory diseases. Hence, that is an important factor in increasing the demand for intranasal drug delivery products in the market.
This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:
The Global Intranasal Drug Delivery market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Purchase Report @ http://www.sandlerresearch.org/purchase?rname=21398.
The report recognizes the following companies as the key players in the Global Intranasal Drug Delivery Market: Becton, Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson and Novartis AG.
Other Prominent Vendors in the market are: Actiza Pharmaceutical, Aptar Group, Korten Pharmaceuticals, OptiNose, Patheon ,Vee Remedies and Zymeth Wellness.
Further, the report states that one of the major challenges in the market is a risk of overdosing, which causes various side-effects.
Key Questions Answered in this Report
Global Operating Room Equipment Market 2014-2018: In terms of equipment, the Global Operating Room Equipment market is segmented into five: Operating Tables, Operating Room Lights, Surgical Imaging Displays, Operating Room Integration Systems, and Surgical Booms.
Medical Electrodes Market in Europe 2014-2018: Key Vendors
Other Prominent Vendors
Global Heart Defect Closure Devices Market 2014-2018:
Sandlerresearch.org (http://www.sandlerresearch.org/) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.